CStone Pharmaceuticals (2616) Updates Joint Company Secretary Qualification and Announces Personnel Changes

Bulletin Express

Feb 06

CStone Pharmaceuticals (the Company) announced that the Stock Exchange of Hong Kong has confirmed the qualification of Joint Company Secretary Ms. Ni under Rule 3.28 of the Listing Rules, effective upon the expiry of a waiver on January 17, 2026. As a result, Ms. Yung resigned as a Joint Company Secretary on February 6, 2026, and Ms. Ni continues as the sole company secretary.

The Company also noted that Ms. Yung resigned as an authorized representative in tandem with her departure from the Joint Company Secretary role. Ms. Ni has assumed the authorized representative position effective February 6, 2026, joining Dr. Yang in that capacity. Meanwhile, Ms. Yung remains as the process agent in Hong Kong. The Company’s board expressed gratitude to Ms. Yung for her contributions during her tenure.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1175414841"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1175414841\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1175414841?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-06 18:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1175414841","market":"us","top_or_hot":-1,"title":"CStone Pharmaceuticals (2616) Updates Joint Company Secretary Qualification and Announces Personnel Changes","media":"Bulletin Express","content":"<p>CStone Pharmaceuticals (the Company) announced that the Stock Exchange of Hong Kong has confirmed the qualification of Joint Company Secretary Ms. Ni under Rule 3.28 of the Listing Rules, effective upon the expiry of a waiver on January 17, 2026. As a result, Ms. Yung resigned as a Joint Company Secretary on February 6, 2026, and Ms. Ni continues as the sole company secretary.</p>\n<p>The Company also noted that Ms. Yung resigned as an authorized representative in tandem with her departure from the Joint Company Secretary role. Ms. Ni has assumed the authorized representative position effective February 6, 2026, joining Dr. Yang in that capacity. Meanwhile, Ms. Yung remains as the process agent in Hong Kong. The Company’s board expressed gratitude to Ms. Yung for her contributions during her tenure.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CStone Pharmaceuticals (2616) Updates Joint Company Secretary Qualification and Announces Personnel Changes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCStone Pharmaceuticals (2616) Updates Joint Company Secretary Qualification and Announces Personnel Changes\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-02-06 18:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CStone Pharmaceuticals (the Company) announced that the Stock Exchange of Hong Kong has confirmed the qualification of Joint Company Secretary Ms. Ni under Rule 3.28 of the Listing Rules, effective upon the expiry of a waiver on January 17, 2026. As a result, Ms. Yung resigned as a Joint Company Secretary on February 6, 2026, and Ms. Ni continues as the sole company secretary.</p>\n<p>The Company also noted that Ms. Yung resigned as an authorized representative in tandem with her departure from the Joint Company Secretary role. Ms. Ni has assumed the authorized representative position effective February 6, 2026, joining Dr. Yang in that capacity. Meanwhile, Ms. Yung remains as the process agent in Hong Kong. The Company’s board expressed gratitude to Ms. Yung for her contributions during her tenure.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02616","symbol_name":"基石药业-B","start_time":0,"source_url":"","article_id":"1175414841","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1175414841","pubTimestamp":1770373335,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"CStone Pharmaceuticals (the Company) announced that the Stock Exchange of Hong Kong has confirmed the qualification of Joint Company Secretary Ms. Ni under Rule 3.28 of the Listing Rules, effective...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02616":"基石药业-B"},"translate_title":"基石药业(2616)更新联席公司秘书资格公布人事变动","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02616":1},"content_text":"CStone Pharmaceuticals (the Company) announced that the Stock Exchange of Hong Kong has confirmed the qualification of Joint Company Secretary Ms. Ni under Rule 3.28 of the Listing Rules, effective upon the expiry of a waiver on January 17, 2026. As a result, Ms. Yung resigned as a Joint Company Secretary on February 6, 2026, and Ms. Ni continues as the sole company secretary.\nThe Company also noted that Ms. Yung resigned as an authorized representative in tandem with her departure from the Joint Company Secretary role. Ms. Ni has assumed the authorized representative position effective February 6, 2026, joining Dr. Yang in that capacity. Meanwhile, Ms. Yung remains as the process agent in Hong Kong. The Company’s board expressed gratitude to Ms. Yung for her contributions during her tenure.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}